4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000950170-25-050857
CEO sold 30,663 shares at $18.35 ($562,684)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Evans John M. CEO | 2025-04-01 | Sale 10b5-1 | −30,663 | $18.35 | $562,684 | 986,249 | D |
| Open-market sales · 30,663 sh · avg $18.35 · $562,684 | |||||||
Loading xslF345X05/ownership.xml…